ArticleDiabetes, obesity & metabolism2026

Real-World Effectiveness and Safety of iGlarLixi in People With Type 2 Diabetes in LATAM Region: A Subanalysis of the SUCCESS Study.

Juan Manuel Arteaga-Diaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.